Plasma α2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone

Kidney International

Volumn 54, Issue 2, 1998, Pages 530-535

  De Sain Van Der Velden, Monique G M ^a   Rabelink, Ton J ^b   Reijngoud, Dirk Jan ^b   Gadellaa, Mireille M ^b   Voorbij, Hieronymus A M ^b   Stellaard, Frans ^b   Kaysen, George A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Analbuminemia; FCR; Gas chromatography combustion isotope ratio mass spectrometry; Nephrotic syndrome; Protein; Stable isotopes; Valine tRNA pool; 2 macroglobulin

Indexed keywords

ALPHA 2 MACROGLOBULIN; CARBON 13; PROTEINASE INHIBITOR; VALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS;

EID: 0031823007     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00018.x     Document Type: Article

References (37)

1. MUNCK PETERSEN C, CHRISTIANSEN BS, HEICKENDORFF L, INGERSLEV J: Synthesis and secretion of alpha 2-macroglobulin by human hepatocytes in culture. Eur J Clin Invest 18:543-548, 1998
2. DZIEGIELEWSKA KM, SAUNDERS NR, SCHEJTER EJ, ZAKUT H, ZEVINSONKIN D, ZISLING R, SOREQ H: Synthesis in plasma proteins in fetal. adult and neoplastic human brain tissue. Develop Biol 115:93-104, 1997
3. SOTTRUP JENSEN L.: Alpha-macroglobulins: Structure, shape, and mechanism of proteinase complex formation. J Biol Chem 264:11539-11542, 1989
4. FEIGE JJ, NEGOESCU A, KERAMIDAS M, SOUCHELNITSKIY S, CHAMBAZ EM: Alpha 2-macroglobulin: A binding protein for transforming growth factor-beta and various cytokines. Horm Res 45:227-232, 1996
5. TUNSTALL AM, MERRIMAN JM, MILNE I, JAMES K: Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol 28:133-139, 1975
6. STENBJERG S: Inherited alpha 2 macroglobulin deficiency. Thromb Res 22:491-495, 1981
7. BERGQVIST D, NILSSON IM: Hereditary alpha 2-macroglobulin deficieney. Scand J Haematol 23:433-436, 1979
8. VAZIRI ND, GONZALES EC, SHAYESTEHEAR B, BARTON CH: Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 124:118-124, 1994
9. RYDZEWSKI A, MYSLIWIEC M, SOSZKA J: Concentration of three thrombin inhibitors in the nephrotic syndrome in adults. Nephron 42:200-203, 1986 [published erratum appears in Nephron 43:312, 1986]
10. BONEU B, BOUISSOU F, ABBAL M, SIE P, CARANOBE C, BARTHE P: Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome. Thromb Haemost 46:623-625, 1981
11. MCGINLEY E, LOWE GD, BOULTON JONES M, FORBES CD, PRENTICE CR: Blood viscosity and haemostasis in the nephrotic syndrome. Thromb Haemost 49:155-157, 1983
12. MAHAJAN SK: Zinc in kidney disease. J Am Coll Nutr 8:296-304, 1989
13. TUMER N, BASKAN S, ARCASOY A, CAVDAR AO, EKIM M: Zinc metabolism in nephrotic syndrome. (letter) Nephron 52:95, 1989
14. SCHMIDT B, MITCHELL L, OFOSU FA, ANDREW M: Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma. Thromb Haemost 62:1074-1077, 1989
15. STEVENSON F, GREENE S, KAYSEN GA: Serum alpha 2 macroglobulin and alpha 1 inhibitor 3 concentrations are increased in hypoalbuminemia by post-transcriptional mechanisms. Kidney Int 53:67-75, 1998
16. KLUTHE R, HAGEMANN U, KLEINE N: The turnover of alpha 2 Macroglobulins in the nephrotic syndrome. Vox Sang 12:308-311, 1967
17. DE SAIN-VAN DER VELDEN MGM, KAYSEN GA, DE MEER K, STELLAARD F, VOORBIJ HAM, REIJNGOUD DJ, RABELINK TJ, KOOMANS HA: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients. Measurements with stable isotopes. Kidney Int 53:181-188, 1998
18. GEERS AB, KOOMANS HA, BOER P, DORHOUT MEES EJ: Plasma and blood volumes in patients with the nephrotic syndrome. Nephron 38:170-173, 1984
19. OHLSSON K, LAURELL CB: The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med 51:87-92, 1976
20. KRISTENSEN T, MOESTRUP SK, GLIEMANN J, BENDTSEN L, SAND O, SOTTRUP JENSEN L: Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is the alpha 2-macroglobulin receptor. FEBS Lett 276:151-155, 1990
21. DE SAIN-VAN DER VELDEN MGM, KAYSEN GA, BARRETT HA, STELLAARD F, GADELLAA MM, VOORBIJ HAM, REIJNGOUD DJ, RABELINK TJ: Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int 53:994-1001, 1998
22. CHAPPELL DA, FRY GL, WAKNITZ MA, MUHONEN LE, PLADET MW, IVERIUS PH, STRICKLAND DK: Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. J Biol Chem 268: 14168-14175, 1993
23. LUPU F, HEIM D, BACHMANN F, KRUITHOF EK: Expression of LDL receptor-related protein/alpha 2-macroglobulin receptor in human normal and atherosclerotic arteries. Arterioscler Thromb 14:1438-1444, 1994
24. JAHOOR F, SIVAKUMAR B, DEL-ROSARIO M, FRAZER EM: Isolation of acute-phase proteins from plasma for determination of fractional synthesis rates by a stable isotope tracer technique. Anal Biochem 236:95-100, 1996
25. HUŠEK P: Rapid deriatization and gas chromatographic determination of amino acids. J Chromatogr 552:259-299, 1991
26. HARPEL PC: Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure. J Exp Med 138:508-521, 1973
27. VIRCA GD, TRAVIS J, HALL PK, ROBERTS RC: Purification of human alpha-2-macroglobulin by chromatography on Cibacron Blue Sepharose. Anal Biochem 89:274-278, 1978
28. SWENSON RP, HOWARD JB: Structural characterization of human alpha2-macroglobulin subunits. J Biol Chem 254:4452-4456, 1979
29. HALL PK, ROBERTS RC: Physical and chemical properties of human plasma alpha2-macroglobulin. Biochem J 173:27-38, 1978
30. VIKBLADH I: Studies on zinc in blood. Scand J Clin Lab Invest 3:1-74, 1951
31. SHIRAISHI N, YAMAMOTO H, KIMOTO M, SHIRAGAMI T, TOGAMI I, NIIYA H, AONO K: Distribution of protein-bound zinc in serum of analbuminemic rat. Biochem Biophys Res Commun 125:45-51, 1984
32. KIILERICH S, CHRISTIANSEN C: Distribution of serum zinc between albumin and alpha 2-macroglobulin in patients with different zinc metabolic disorders. Clin Chim Acta 154:1-6, 1986
33. SCHECHTER PJ, GIROUX EL, SCHLIENGER JL, HOENIG V, SJOERDSMA A: Distribution of serum zinc between albumin and alpha2-macroglobulin in patients with decompensated hepatic cirrhosis. Eur J Clin Invest 6:147-150, 1976
34. GANDRILLE S, JOUVIN MH, TOULON P, REMY P, FIESSINGER JN, RONCATO M, MOATTI N, AIACH M: A study of fibrinogen and fibrinolysis in 10 adults with nephrotic syndrome. Thromb Haemost 59:445-450, 1988
35. DE STEFANO V, TRIOLO L, DE MARTINI D, FERRELLI R, MORI R, LEONE G: Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome. J Lab Clin Med 109:550-555, 1987
36. NORBERG R, BIRKE G, HEDFORS E, PLANTIN LO: Metabolism of alpha 2-macroglobulin, in Plasma Protein Metabolism, edited by ROTHSCHILD MA, WALDMANN T, New York, Academic Press, 1970, pp 427-435
37. THALER E, BALZAR E, KOPSA H, PINGGERA WF: Acquired antithrombin III deficiency in patients with glomerular proteinuria. Haemostasis 7:257-272, 1978